These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24170081)

  • 1. [Personalised medicine in psychiatry and psychotherapy. A review of the current state-of-the-art in the biomarker-based early recognition of psychoses].
    Koutsouleris N; Ruhrmann S; Falkai P; Maier W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1522-30. PubMed ID: 24170081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Personalised medicine for the diagnosis and treatment of allergic diseases].
    Vieths S; Bieber T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1531-7. PubMed ID: 24170082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early biomarkers of psychosis.
    Freedman R; Ross R; Leonard S; Myles-Worsley M; Adams CE; Waldo M; Tregellas J; Martin L; Olincy A; Tanabe J; Kisley MA; Hunter S; Stevens KE
    Dialogues Clin Neurosci; 2005; 7(1):17-29. PubMed ID: 16060593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relevance of biomarkers for personalised medicine].
    Großhennig A; Benda N; Koch A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1480-8. PubMed ID: 24084852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promise of protein glycosylation for personalised medicine.
    Almeida A; Kolarich D
    Biochim Biophys Acta; 2016 Aug; 1860(8):1583-95. PubMed ID: 26987810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Personalised medicine for psychosis].
    Veling W; Sommer IEC; Bruggeman R; de Haan L
    Tijdschr Psychiatr; 2018; 60(3):161-165. PubMed ID: 29521403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multimodal approach to investigate biomarkers for psychosis in a clinical setting: the integrative neuroimaging studies in schizophrenia targeting for early intervention and prevention (IN-STEP) project.
    Koike S; Takano Y; Iwashiro N; Satomura Y; Suga M; Nagai T; Natsubori T; Tada M; Nishimura Y; Yamasaki S; Takizawa R; Yahata N; Araki T; Yamasue H; Kasai K
    Schizophr Res; 2013 Jan; 143(1):116-24. PubMed ID: 23219075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Personalised medicine. Aims and challenges].
    Bieber T; Broich K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1468-72. PubMed ID: 24170075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intervention in individuals at ultra-high risk for psychosis: a review and future directions.
    McGorry PD; Nelson B; Amminger GP; Bechdolf A; Francey SM; Berger G; Riecher-Rössler A; Klosterkötter J; Ruhrmann S; Schultze-Lutter F; Nordentoft M; Hickie I; McGuire P; Berk M; Chen EY; Keshavan MS; Yung AR
    J Clin Psychiatry; 2009 Sep; 70(9):1206-12. PubMed ID: 19573499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers in psychosis: an approach to early identification and individualized treatment.
    Mirzakhanian H; Singh F; Cadenhead KS
    Biomark Med; 2014; 8(1):51-7. PubMed ID: 24325224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early detection of psychotic disorders].
    Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
    Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical markers of impending psychosis.
    Emanuele E; Martinelli V; Abbiati V; Fusar-Poli P; Politi P
    Curr Pharm Des; 2012; 18(4):505-9. PubMed ID: 22239581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosis in neurodegenerative disorders: recent developments.
    Karameh WK; Murari G; Schweizer TA; Munoz DG; Fischer CE
    Curr Opin Psychiatry; 2019 Mar; 32(2):117-122. PubMed ID: 30520740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Basel early-detection-of-psychosis (FEPSY)-study--design and preliminary results.
    Riecher-Rössler A; Gschwandtner U; Aston J; Borgwardt S; Drewe M; Fuhr P; Pflüger M; Radü W; Schindler Ch; Stieglitz RD
    Acta Psychiatr Scand; 2007 Feb; 115(2):114-25. PubMed ID: 17244175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cycloid psychoses -- from clinical concepts to biological foundations.
    Jabs BE; Pfuhlmann B; Bartsch AJ; Cetkovich-Bakmas MG; Stöber G
    J Neural Transm (Vienna); 2002 May; 109(5-6):907-19. PubMed ID: 12111477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring the tridosha symptoms of unmāda (psychosis): a preliminary study.
    Suchitra SP; Devika HS; Gangadhar BN; Nagarathna R; Nagendra HR; Kulkarni R
    J Altern Complement Med; 2010 Apr; 16(4):457-62. PubMed ID: 20423215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pre-psychotic states--contemporary diagnostic and therapeutic issues. Part II. The biological markers of the risk of schizophrenia. Therapy of pre-psychotic states].
    Szulc A; Czernikiewicz A
    Psychiatr Pol; 2007; 41(1):17-27. PubMed ID: 17494411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early detection and early intervention in first episode psychosis].
    Bourgin J; Krebs MO
    Rev Prat; 2013 Mar; 63(3):336-42. PubMed ID: 23687756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advanced directives in psychiatry: A review of the qualitative literature, a state-of-the-art and viewpoints].
    Maître E; Debien C; Nicaise P; Wyngaerden F; Le Galudec M; Genest P; Ducrocq F; Delamillieure P; Lavoisy B; Walter M; Dubois V; Vaiva G
    Encephale; 2013 Sep; 39(4):244-51. PubMed ID: 23537636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Personalization of Therapy: Molecular Profiling Technologies and Their Application.
    Zeron-Medina J; Ochoa de Olza M; Braña I; Rodon J
    Semin Oncol; 2015 Dec; 42(6):775-87. PubMed ID: 26615125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.